Risks of Adverse Events in Treated Chronic Hepatitis C Patients with Cirrhosis Compared to without Cirrhosis in Real-World Settings

被引：0
|
作者：
Shen, Sophie W. [1 ]
Ives, Jennifer Wood [1 ]
Hines, Patricia [2 ]
Dimitrova, Dessislava [1 ]
机构：
[1] Bristol Myers Squibb Co, Global Pharmacovigilance & Epidemiol, Hopewell, NJ USA
[2] Bristol Myers Squibb Co, Ctr Observat Res & Data Sci, Hopewell, NJ USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2013年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
128
引用
收藏
页码：65 / 66
页数：2
相关论文
共 50 条
  • [1] Effects of cirrhosis, interferon and azathioprine on adverse events in patients with chronic hepatitis C treated with ribavirin
    Thevenot, T
    Mathurin, P
    Moussalli, J
    Perrin, M
    Plassart, F
    Blot, C
    Opolon, P
    Poynard, T
    JOURNAL OF VIRAL HEPATITIS, 1997, 4 (04) : 243 - 253
  • [2] ADVERSE EVENTS IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGIFN-ALFA AND RIBAVIRIN IN REAL-WORLD SETTING
    Shen, Sophie W.
    Dimitrova, Dessislava
    Hines, Patricia
    Gomez-Caminero, Andres
    HEPATOLOGY, 2011, 54 : 855A - 856A
  • [3] Prevalence of Nephrolithiasis is Significantly Higher in Hepatitis C Cirrhosis Compared to Patients Without Cirrhosis
    Farooq, Imran S.
    Heuman, Douglas M.
    Bajaj, Jasmohan S.
    GASTROENTEROLOGY, 2011, 140 (05) : S459 - S460
  • [4] Intestinal microbiota in patients with chronic hepatitis C with and without cirrhosis compared with healthy controls
    Heidrich, Benjamin
    Vital, Marius
    Plumeier, Iris
    Doescher, Nico
    Kahl, Silke
    Kirschner, Janina
    Ziegert, Szilvia
    Solbach, Philipp
    Lenzen, Henrike
    Potthoff, Andrej
    Manns, Michael Peter
    Wedemeyer, Heiner
    Pieper, Dietmar Helmut
    LIVER INTERNATIONAL, 2018, 38 (01) : 50 - 58
  • [5] Real world experience in treatment of chronic hepatitis C in patients with compensated and decompensated cirrhosis
    Rollin, Francois
    Mcnamara, Maeve
    Aleuy, Lana
    Lom, Jennifer
    Chirumamilla, Siri
    Molinari, Alexander
    Miller, Lesley
    Fluker, Shelly-Ann
    FUTURE VIROLOGY, 2024, 19 (10-11) : 393 - 399
  • [6] HIGHER HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN CHRONIC HEPATITIS C (CHC) PATIENTS AFTER HEPATITIS C VIRUS (HCV) CURE COMPARED TO TREATED CHRONIC HEPATITIS B (CHB): RESULTS FROM A MULTINATIONAL REAL-WORLD COHORT OF PATIENTS WITH CIRRHOSIS
    Park, Jiyoon
    Tran, Sally
    Ogawa, Eiichi
    Huang, Chung-Feng
    Toyoda, Hidenori
    Chen, Chien Hung
    Yeh, Ming-Lun
    Tseng, Cheng-Hao
    Hsu, Yao-Chun
    Kawashima, Keigo
    Preda, Carmen
    Istratescu, Doina
    Yasuda, Satoshi
    Nozaki, Akito
    Chuma, Makoto
    Oh, Hyunwoo
    Shim, Jae-Jun
    Jeong, Soung Won
    An, Jihyun
    Ahn, Sang Bong
    Kim, Sung Eun
    Yoon, Eileen
    Lee, Han Ah
    Kim, Hyoung Su
    Cho, Yong Kyun
    Uojima, Haruki
    Trinh, Huy
    Atsukawa, Masanori
    Itokawa, Norio
    Okubo, Tomomi
    Abe, Hiroshi
    Lee, Dong Hyun
    Jun, Mi Jung
    Landis, Charles
    Liu, Joanne
    Enomoto, Masaru
    Watanabe, Tsunamasa
    Ji, Fanpu
    Wang, Wenjun
    Yu, Li
    Xie, Qing
    Fukunishi, Shinya
    Asai, Akira
    Yokohama, Keisuke
    Ishikawa, Toru
    Liu, Li
    Li, Junyi
    Takahashi, Hirokazu
    Inoue, Kaori
    Eguchi, Yuichiro
    HEPATOLOGY, 2022, 76 : S377 - S379
  • [7] REAL WORLD EXPERIENCE IN TREATMENT OF CHRONIC HEPATITIS C IN PATIENTS WITH CIRRHOSIS AT A SAFETY - NET HOSPITAL
    Rollin, Francois
    Lom, Jennifer E.
    McNamara, Maeve
    Aleuy, Lana
    Chirumamilla, Siri
    Molinari, Alexander
    Miller, Lesley S.
    Fluker, Shelly-Ann
    HEPATOLOGY, 2023, 78 : S738 - S738
  • [8] Real-World Experience of Chronic Hepatitis C-Related Compensated Liver Cirrhosis Treated with Glecaprevir/Pibrentasvir: A Multicenter Retrospective Study
    Su, Pei-Yuan
    Chen, Yang-Yuan
    Lai, Jun-Hung
    Chen, Hung-Ming
    Yao, Chih-Ta
    Liu, I-Ling
    Zeng, Ya-Huei
    Huang, Siou-Ping
    Hsu, Yu-Chun
    Wu, Shun-Sheng
    Siao, Fu-Yuan
    Yen, Hsu-Heng
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (22)
  • [9] SOFOSBUVIR/VELPATASVIR WITH OR WITHOUT RIBAVIRIN FOR CHRONIC HEPATITIS C VIRUS INFECTED PATIENTS WITH LIVER CIRRHOSIS AND CHRONIC KIDNEY DISEASE: REAL-WORLD EXPERIENCE FROM SOUTHWEST CHINA
    Rui, Yang Yong
    Huang, Kang
    Zhao, Zhirong
    Bai, Jinsong
    Wu, Lei
    Li, Junyi
    Li, Shenghao
    Li, Liu
    Li, Haiwen
    Du, Yingrong
    HEPATOLOGY, 2023, 78 : S741 - S741
  • [10] Safety and Efficacy of Sofosbuvir with Ribavirin® in Hepatitis C, Genotype 3 Patients with Cirrhosis: A Real-world Experience
    Butt, Nazish
    Akhar, Ali
    Abbasi, Amanullah
    Reema, Sehrish
    Bin Bagar, Jaffer
    Shaikh, Qurban Hussain
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (02)
12345